Followers | 44 |
Posts | 3169 |
Boards Moderated | 2 |
Alias Born | 01/18/2016 |
Tuesday, January 16, 2024 9:38:24 PM
A Private placement announced DEC 5 2023 added 4.4M shares + 319K warrants.
Prospectus announced today will allow those shares to trade. The 319K warrants may also be exercised.
Currently most shares are held tightly.
All my postings are verified and approved by my dog.
Recent COYA News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 08:26:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 08:20:17 PM
- Coya Therapeutics Provides a Corporate Update and Reports Unaudited First Quarter 2024 Financial Results • Business Wire • 05/09/2024 08:10:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2024 09:21:04 PM
- Coya Therapeutics Presents Updated ALS Biomarker Data at the 2nd Annual Johnson Center Symposium • Business Wire • 04/26/2024 12:15:00 PM
- Coya Therapeutics to Participate in the Mizuho Neuroscience Summit • Business Wire • 04/22/2024 12:15:00 PM
- Coya Therapeutics to Participate in the 3rd Annual ALS Drug Development Summit • Business Wire • 04/18/2024 12:15:00 PM
- Coya Therapeutics Scientific Advisory Board Chairman Dr. Stanley Appel to Present Updated ALS Biomarker Data at the 2nd Annual Johnson Center Symposium • Business Wire • 04/08/2024 12:15:00 PM
- Coya Therapeutics Provides a Corporate Update and Reports Fiscal 2023 Financial Results • Business Wire • 03/19/2024 12:15:00 PM
- Coya Therapeutics to Participate in BTIG Fireside Discussion • Business Wire • 03/12/2024 01:00:00 PM
- Coya Therapeutics Presents ALS Biomarker Data at Society of Neuroimmune Pharmacology Conference • Business Wire • 03/12/2024 12:00:00 PM
- Coya Therapeutics Presents Biomarker Data on Neuroinflammatory Pathways in Frontotemporal Dementia (FTD) at the AD/PD 2024 Conference • Business Wire • 03/06/2024 01:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 01:00:30 AM
- Coya Therapeutics to Present Data on Immune System and Regulatory T Cell (Treg) Contributions in Frontotemporal Dementia (FTD) Patients at AD/PD 2024 Conference • Business Wire • 02/29/2024 01:15:00 PM
- Coya Therapeutics to Present Novel Biomarker Survival Data in Large Cohort of ALS (Amyotrophic Lateral Sclerosis) Patients at Society of Neuroimmune Pharmacology Conference • Business Wire • 02/22/2024 01:15:00 PM
- Coya Therapeutics Issues Letter to Stockholders Highlighting Expansion of COYA 302 into Alzheimer’s Disease and Coya’s Pathway to a “Pipeline in a Product” • Business Wire • 02/21/2024 01:15:00 PM
- Coya Therapeutics Licenses Intellectual Property Rights for Use of Next Generation Immune Modulatory Biologics in Combination with COYA 301 to Enhance Regulatory T Cells (Tregs) in Inflammatory Diseases • Business Wire • 02/13/2024 01:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/03/2024 01:00:19 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/03/2024 01:00:12 AM
- Coya Therapeutics SAB Chairman Dr. Stanley Appel, M.D. Selected as Speaker at the Society of Neuroimmune Pharmacology Conference • Business Wire • 01/29/2024 01:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/19/2024 11:30:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/19/2024 11:30:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/19/2024 11:30:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 01:15:28 PM
- Coya Therapeutics to Participate in Upcoming Chardan Biotech Leadership Call Series • Business Wire • 01/18/2024 01:15:00 PM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM